Pleasanton, CA, United States of America

Geoff McDermott


 

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Geoff McDermott in Polymerase Chain Reaction Technology

Introduction

Geoff McDermott is a notable inventor based in Pleasanton, CA (US). He has made significant contributions to the field of molecular biology, particularly in the development of advanced techniques for polymerase chain reaction (PCR) assays. With a total of 4 patents, his work has had a profound impact on the detection of nucleic acids.

Latest Patents

Among his latest patents, Geoff has developed compositions, methods, and systems for polymerase chain reaction assays. This includes methods, devices, systems, and compositions for detecting nucleic acids in PCR assays, such as droplet digital polymerase chain reaction (ddPCR) assays, utilizing intercalating dyes. Additionally, he has created a dual surfactant system that incorporates at least one fluorosurfactant and one non-ionic non-fluorosurfactant for droplet generation and nucleic acid detection. Another significant patent involves a multiplexed digital assay that features specific and generic reporters, providing a digital assay system that includes methods, apparatus, and compositions for performing target assays in partitions.

Career Highlights

Geoff McDermott is currently employed at Bio-Rad Laboratories, Inc., where he continues to innovate in the field of molecular diagnostics. His expertise in PCR technology has positioned him as a key player in advancing the capabilities of genetic testing and analysis.

Collaborations

Throughout his career, Geoff has collaborated with esteemed colleagues, including John Frederick Regan and Svilen Tzonev. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies in the field.

Conclusion

Geoff McDermott's contributions to polymerase chain reaction technology exemplify the spirit of innovation in molecular biology. His patents and ongoing work at Bio-Rad Laboratories, Inc. continue to shape the future of genetic testing and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…